Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

First oral treatment for women with postpartum depression approved by FDA

August 7, 2023 Research and Development FDA, postpartum depression, treatment, zurzuvae

On 4 August 2023, the US Food and Drug Administration (FDA) approved the use of Zurzuvae for adults with postpartum …
News
Vaccine image

New vaccine research centre opened to prepare for future pandemics

August 7, 2023 Research and Development Immunology, UKHSA, pandemic, vaccine research centre

Ministers have opened a new vaccine research centre at the UK Health and Security Agency’s (UKHSA) Porton Down campus in …
News

FDA approves Merck’s Ervebo vaccine for under 18s

August 4, 2023 Research and Development FDA, Immunology, Vaccine, ebolavirus

On 3 August 2023, the US Food and Drug Administration (FDA) approved Merck’s Ervebo vaccine for children over 12 months. …
News

Evox Therapeutics enters agreement for next generation gene therapy for heart disease

August 4, 2023 Research and Development Cardiology, Evox Therapeutics, Icahn Mount Sinai, cvd, gene therapy

Evox Therapeutics has announced a research collaboration and option agreement with the Icahn School of Medicine at Mount Sinai (Icahn …
News

Targeted chemotherapy to kill all solid tumours developed in preclinical research

August 3, 2023 Research and Development Cancer, Oncology, chemotherapy, pharmaceutical, tumour

Researchers from the City of Hope organisation in the US have released a study confirming the development of AOH1996, a …
News

Biopharmaceutical company EQRx set to be acquired by Revolution Medicines

August 2, 2023 Research and Development EQRx, Pharmacy, biopharmaceutical, pharmaceutical, revolution medicines

On 1 August 2023, Revolution Medicines signed an official agreement confirming the acquisition of the biopharmaceutical company EQRx. The deal …
News
brainss

Proof-of-concept study shows non-invasive brain stimulation efficient as treatment for ADHD in children

August 2, 2023 Research and Development ADHD, Hebrew University of Jerusalem, Psychiatry, brain stimulation, clinical trial, university of surrey

Researchers from the University of Surrey, UK, and the Hebrew University of Jerusalem, Israel, have found that non-invasive brain stimulation …
News

MyMD reports statistically significant results from phase 2 trial for sarcopenia/age-related frailty

August 2, 2023 Research and Development Musculo-skeletal disorder, MyMD, clinical trial, sarcopenia

MyMD Pharmaceuticals has announced statistically significant positive topline results from a phase 2 trial of oral TNF- α inhibitor, MYMD-1 …
News

The NIH’s RECOVER initiative could lead to the first official treatment for long COVID-19

August 1, 2023 Research and Development COVID-19, Infections and infestations, NIH, clinical trials, long covid

As of 31 July 2023, The National Institutes of Health (NIH) launched the first trials of its ‘Researching COVID to …
News
cancer_cells_from_the_breast_cancer_now_tissue_bank_cell_programme

Merck shares data from phase 3 trial for breast cancer treatment

August 1, 2023 Research and Development MSD, Merck, Oncology, breast cancer, keytruda

Merck, also known as MSD outside of the US and Canada, has announced positive results from the phase 3 KEYNOTE-756 …
News

GSK’s Jemperli approved for treatment of endometrial cancer

August 1, 2023 Research and Development FDA, GSK, Jemperli, Oncology, dostarlimab, endometrial cancer

GSK has announced that the US Food and Drug Administration (FDA) has approved Jemperli (dostarlimab) in combination with carboplatin and …
News

Research shows neonatal stem cells could be used as treatment for Crohn’s disease

July 31, 2023 Research and Development Crohn’s disease, Gastrointestinal tract, Stem cells, gastrointestinal

Recent studies from the Ann & Robert H Lurie Children’s Hospital in Chicago have discovered that human neonatal cardiac-derived mesenchymal …
News
pills_spill

Eli Lilly shares data from two phase 3 tirzepatide studies

July 28, 2023 Research and Development Eli Lilly, Obesity, clinical trial, tirzepatide, weight loss

Eli Lilly has announced results from its two phase 3 tirezepatide studies in adult patients with obesity or who are …
News
genes

AstraZeneca’s Alexion partners with Pfizer for rare disease therapies

July 28, 2023 Research and Development Alexion, AstraZeneca, Pfizer, Rare Diseases, genomics, rare disease

Alexion, AstraZeneca’s Rare Disease division, has announced that it has entered a definitive purchase and licence agreement with Pfizer. The …
News
lungs

Hummingbird Bioscience initiates phase 1b trials for sqNSCLC

July 27, 2023 Research and Development Hummingbird Bioscience, Omico, Oncology, clinical trials, sqNSCLC

Hummingbird Bioscience has announced the initiation of two phase 1b clinical trials taking place in Australia. The trials will evaluate …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025